Atrial Fibrillation Resource Center - ModernMedicine
www.fgks.org   »   [go: up one dir, main page]

Topic-Based
Resource Centers

Oral Anticoagulation in Atrial Fibrillation

TOOLBOX
Atrial Fibrillation Risk Stratification Tools For Stroke and Bleeding
Patients with atrial fibrillation are at increased risk of stroke and thomboembolic events. Two risk stratification tools for stroke and one for bleeding can assist clinicians to prescribe therapeutic regimens that balance stroke prevention against bleeding risk.


RELATED TOPICS
Cardiology
Clinical Pharmacology
Family Medicine
Geriatrics
Hypertension
Internal Medicine
Neurology
Orthopedics
Primary Care Medicine
Stroke
Surgery

CLINICAL ARTICLES
Updated Strategies for Managing Nonvalvular Atrial Fibrillation in Primary Care A survey among healthcare providers and patients indicates there is a need for better communication with patients about AF and stroke since less than half of the patients in the survey report asking about their own risk of stroke or ask about stroke prevention. Risk stratification systems for stroke and bleeding help physicians to engage a more informed decision-making process with their patients. More...
 
 
Novel and Emerging Oral Anticoagulation Therapy in Atrial Fibrillation: Clinical Perspectives for Primary Care Two new classes of oral anticoagulants—direct factor IIa (thrombin) inhibitors and factor Xa inhibitors—promise safe, easy to use, and effective alternatives to warfarin for treating nonvalvular AF. These agents, with their predictable drug profiles that allow for fixed dosing and no therapeutic monitoring, offer new approaches to AF in primary care. More...

ADVERTISEMENT

CME
Alyce Visit 1: An Elderly Woman with a Pacemaker Presenting with New Onset Atrial Fibrillation Release Date: July 11, 2011
Expiration Date: July 10, 2012

Upon completion of this interactive case, involving the initial visit of an elderly woman with a pacemaker presenting with new onset atrial fibrillation (AF), participants should be able to:

  • Cite evidence on which to base an AF management strategy that considers heart rate control as well as rhythm control
  • Discuss how novel and emerging antiarrhythmic therapies can best be integrated into practice to reduce AF-related morbidity and mortality
  • Outline an individual management strategy for AF patient cases based on AF features, presentation, and guideline recommendations.

View this Activity


CONTRIBUTORCONTRIBUTOREDITORIAL SUPPORT
Alexander Turpie Alexander Turpie, MD, FRCPC
Dr. Turpie is a professor of medicine at McMaster University, and an internist on the staff of Hamilton Health Sciences, Hamilton, Ontario.
More…
David C. Willis David C. Willis, MD
Dr. Willis practices family medicine in Ocala, Fla. He serves as medical director for Healthy Ocala, a developing patient-centric health information exchange in north central Florida.
More…
Deborah KaplanDeborah Kaplan
Editorial and media consultant

ADVERTISEMENT



Click here